| Loss of asthma control after cessation of omalizumab treatment: real life data I Kupryś-Lipińska, P Kuna Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii …, 2014 | 54 | 2014 |
| Mediators of inflammation in nasal lavage from aspirin intolerant patients after aspirin challenge M Kupczyk, Z Kurmanowska, I Kupryś-Lipińska, M Bocheńska-Marciniak, ... Respiratory medicine 104 (10), 1404-1409, 2010 | 41 | 2010 |
| The effect of omalizumab on eosinophilic inflammation of the respiratory tract in patients with allergic asthma I Kupryś-Lipińska, K Molińska, P Kuna Advances in Respiratory Medicine 84 (4), 232-243, 2016 | 33 | 2016 |
| Safety and efficacy of mepolizumab in hypereosinophilic syndrome: an open-label extension study GJ Gleich, F Roufosse, G Chupp, S Faguer, B Walz, A Reiter, SW Yancey, ... The Journal of Allergy and Clinical Immunology: In Practice 9 (12), 4431 …, 2021 | 32 | 2021 |
| Impact of chronic obstructive pulmonary disease (COPD) on patient’s life and his family I Kupryś-Lipińska, P Kuna Advances in Respiratory Medicine 82 (2), 82-95, 2014 | 31 | 2014 |
| Effectiveness of the Polish program for the treatment of severe allergic asthma with omalizumab: a single-center experience I Kupryś-Lipińska, P Majak, J Molinska, P Kuna BMC Pulmonary Medicine 16, 1-9, 2016 | 25 | 2016 |
| The underdiagnosis and undertreatment of asthma in general population of the Lodz Province (Poland) I Kupryś-Lipińska, A Elgalal, P Kuna Advances in Respiratory Medicine 78 (1), 21-27, 2010 | 23 | 2010 |
| The Step Further to Understand the Role of Cytosolic Phospholipase A2 Alpha and Group X Secretory Phospholipase A2 in Allergic Inflammation: Pilot Study E Pniewska, M Sokolowska, I Kupryś-Lipińska, M Przybek, P Kuna, ... BioMed Research International 2014, 2014 | 22 | 2014 |
| The analysis of the factors influencing the development of glucocorticoid resistance in the etiopathogenesis of severe bronchial asthma M Panek, T Pietras, I Kupryś-Lipińska, P Górski, P Kuna, J Szemraj Postepy biochemii 56 (4), 373-382, 2010 | 22 | 2010 |
| Urban-rural differences in the prevalence of atopic diseases in the general population in Lodz Province (Poland) I Kupryś-Lipińska, A Elgalal, P Kuna Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii …, 2009 | 22 | 2009 |
| Exacerbating factors induce different gene expression profiles in peripheral blood mononuclear cells from asthmatics, patients with chronic obstructive pulmonary disease and … E Pniewska, M Sokolowska, I Kupryś-Lipińska, D Kacprzak, P Kuna, ... International Archives of Allergy and Immunology 165 (4), 229-243, 2015 | 18 | 2015 |
| Control of asthma in adults treated with beclomethasone and formoterol in extrafine particle formulation in a real-life setting in Poland: the CASPER noninterventional … P Kuna, I Kupryś-Lipińska, T Dębowski Pol Arch Med Wewn 125 (10), 731-740, 2015 | 18 | 2015 |
| Omalizumab in pregnant women treated due to severe asthma: two case reports of good outcomes of pregnancies I Kupryś-Lipińska, D Tworek, P Kuna Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii …, 2014 | 16 | 2014 |
| Mepolizumab reduces hypereosinophilic syndrome flares irrespective of blood eosinophil count and interleukin-5 ME Rothenberg, F Roufosse, S Faguer, GJ Gleich, J Steinfeld, ... The Journal of Allergy and Clinical Immunology: In Practice 10 (9), 2367 …, 2022 | 13 | 2022 |
| Effectiveness of omalizumab in a patient with a life-threatening episode of bronchospasm and larynx angioedema after exposure to house dust I Kupryś-Lipińska, P Korczyńska, D Tworek, P Kuna Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii …, 2014 | 13 | 2014 |
| Skin prick test with inhaled allergens in the general population of Lodz province I Kupryś-Lipińska, A Elgalal, P Kuna Advances in Respiratory Medicine 77 (3), 229-234, 2009 | 13 | 2009 |
| Biomarkers for predicting response to aspirin therapy in aspirin‐exacerbated respiratory disease KE Tyrak, K Pajdzik, B Jakieła, I Kupryś‐Lipińska, A Ćmiel, R Kacorzyk, ... Clinical & Experimental Allergy 51 (8), 1046-1056, 2021 | 12 | 2021 |
| Sputum biomarkers during aspirin desensitization in nonsteroidal anti-inflammatory drugs exacerbated respiratory disease KE Tyrak, I Kupryś-Lipińska, E Czarnobilska, B Jakieła, K Pajdzik, A Ćmiel, ... Respiratory Medicine 152, 51-59, 2019 | 10 | 2019 |
| Water in the urban space and the health of residents I Kupryś-Lipińska, P Kuna, I Wagner Water City Sendzimir Found. Kraków 88, 47-55, 2014 | 10 | 2014 |
| Late Breaking Abstract-Overprescription of short-acting beta2-agonists in asthma management? Pharmacy reports from 91,673 patients in Poland M Kupczyk, W Barg, G Bochenek, G Brożek, D Brzostek, P Dąbrowiecki, ... European Respiratory Journal 54 (suppl 63), 2019 | 9 | 2019 |
